Demographics and Risk Factors by Mycoplasma genitalium Test Results Among Male Patients Presenting Penile Discharge Symptoms at AIDS Healthcare Foundation's Wellness on Western Walk-in Sexual Health Clinic in Los Angeles County, CA, March–August 2023
| . | Mycoplasma genitalium test results . | . | |
|---|---|---|---|
| . | Negative . | Reactive . | Total . |
| N (column %) . | N (column %) . | N (column %) . | |
| Age group, years | |||
| 18–24 | 2 (2.3) | 1 (9.1) | 3 (3.1) |
| 25–29 | 23 (26.4) | 2 (18.2) | 25 (25.5) |
| 30–34 | 25 (28.7) | 4 (36.4) | 29 (29.6) |
| 35–39 | 21 (24.1) | 2 (18.2) | 23 (23.5) |
| 40+ | 16 (18.4) | 2 (18.2) | 18 (18.4) |
| Race | |||
| Asian | 4 (4.6) | 0 (0.0) | 4 (4.1) |
| Black/African American | 18 (20.7) | 5 (45.5) | 23 (23.5) |
| Native Hawaiian/Pacific Islander | 2 (2.3) | 0 (0.0) | 2 (2.0) |
| White | 28 (32.2) | 4 (36.4) | 32 (32.7) |
| Other/refused | 35 (40.2) | 2 (18.2) | 37 (37.8) |
| Ethnicity | |||
| Hispanic/Latino | 37 (42.5) | 3 (27.3) | 40 (40.8) |
| Not Hispanic/Latino | 43 (49.4) | 6 (54.5) | 49 (50.0) |
| Other/refused | 7 (8.0) | 2 (18.2) | 9 (9.2) |
| Sexual orientation | |||
| Gay | 44 (50.6) | 7 (63.6) | 51 (52.0) |
| Bisexual | 16 (18.4) | 1 (9.1) | 17 (17.3) |
| Heterosexual | 19 (21.8) | 2 (18.2) | 21 (21.4) |
| Other/refused | 8 (9.2) | 1 (9.1) | 9 (9.2) |
| HIV status | |||
| Living with HIV | - | 3 (27.3) | - |
| Not living with HIV | - | 8 (72.7) | - |
| Condomless sex in the past 12 months | |||
| Condomless sex | - | 5 (45.5) | - |
| No condomless sex | - | 0 (0.0) | - |
| Unknown/refused | - | 6 (54.5) | - |
| Number of sexual partners | |||
| 0–1 | - | 0 (0.0) | - |
| 2–9 | - | 3 (27.3) | - |
| 10–19 | - | 3 (27.3) | - |
| 20–29 | - | 0 (0.0) | - |
| 30–39 | - | 0 (0.0) | - |
| 40+ | - | 2 (18.2) | - |
| Unknown/refused | - | 3 (27.3) | - |
| STI coinfection | |||
| No coinfection | - | 6 (54.5) | - |
| Gonorrhea only | - | 4 (36.4) | - |
| Chlamydia and syphilis | - | 1 (9.1) | - |
| Antibiotic resistance | - | ||
| No resistance | - | 1 (9.1) | - |
| Macrolide -23S rRNA | - | 9 (81.8) | - |
| Fluoroquinolone-parC | - | 0 (0.0) | - |
| Fluoroquinolone-gyrA | - | 0 (0.0) | - |
| Macrolide -23S rRNA and fluoroquinolone-parC | - | 1 (9.1) | - |
| Total (row %) | 87 (88.8) | 11 (11.2) | 98 (100.0) |
| . | Mycoplasma genitalium test results . | . | |
|---|---|---|---|
| . | Negative . | Reactive . | Total . |
| N (column %) . | N (column %) . | N (column %) . | |
| Age group, years | |||
| 18–24 | 2 (2.3) | 1 (9.1) | 3 (3.1) |
| 25–29 | 23 (26.4) | 2 (18.2) | 25 (25.5) |
| 30–34 | 25 (28.7) | 4 (36.4) | 29 (29.6) |
| 35–39 | 21 (24.1) | 2 (18.2) | 23 (23.5) |
| 40+ | 16 (18.4) | 2 (18.2) | 18 (18.4) |
| Race | |||
| Asian | 4 (4.6) | 0 (0.0) | 4 (4.1) |
| Black/African American | 18 (20.7) | 5 (45.5) | 23 (23.5) |
| Native Hawaiian/Pacific Islander | 2 (2.3) | 0 (0.0) | 2 (2.0) |
| White | 28 (32.2) | 4 (36.4) | 32 (32.7) |
| Other/refused | 35 (40.2) | 2 (18.2) | 37 (37.8) |
| Ethnicity | |||
| Hispanic/Latino | 37 (42.5) | 3 (27.3) | 40 (40.8) |
| Not Hispanic/Latino | 43 (49.4) | 6 (54.5) | 49 (50.0) |
| Other/refused | 7 (8.0) | 2 (18.2) | 9 (9.2) |
| Sexual orientation | |||
| Gay | 44 (50.6) | 7 (63.6) | 51 (52.0) |
| Bisexual | 16 (18.4) | 1 (9.1) | 17 (17.3) |
| Heterosexual | 19 (21.8) | 2 (18.2) | 21 (21.4) |
| Other/refused | 8 (9.2) | 1 (9.1) | 9 (9.2) |
| HIV status | |||
| Living with HIV | - | 3 (27.3) | - |
| Not living with HIV | - | 8 (72.7) | - |
| Condomless sex in the past 12 months | |||
| Condomless sex | - | 5 (45.5) | - |
| No condomless sex | - | 0 (0.0) | - |
| Unknown/refused | - | 6 (54.5) | - |
| Number of sexual partners | |||
| 0–1 | - | 0 (0.0) | - |
| 2–9 | - | 3 (27.3) | - |
| 10–19 | - | 3 (27.3) | - |
| 20–29 | - | 0 (0.0) | - |
| 30–39 | - | 0 (0.0) | - |
| 40+ | - | 2 (18.2) | - |
| Unknown/refused | - | 3 (27.3) | - |
| STI coinfection | |||
| No coinfection | - | 6 (54.5) | - |
| Gonorrhea only | - | 4 (36.4) | - |
| Chlamydia and syphilis | - | 1 (9.1) | - |
| Antibiotic resistance | - | ||
| No resistance | - | 1 (9.1) | - |
| Macrolide -23S rRNA | - | 9 (81.8) | - |
| Fluoroquinolone-parC | - | 0 (0.0) | - |
| Fluoroquinolone-gyrA | - | 0 (0.0) | - |
| Macrolide -23S rRNA and fluoroquinolone-parC | - | 1 (9.1) | - |
| Total (row %) | 87 (88.8) | 11 (11.2) | 98 (100.0) |
Demographics and Risk Factors by Mycoplasma genitalium Test Results Among Male Patients Presenting Penile Discharge Symptoms at AIDS Healthcare Foundation's Wellness on Western Walk-in Sexual Health Clinic in Los Angeles County, CA, March–August 2023
| . | Mycoplasma genitalium test results . | . | |
|---|---|---|---|
| . | Negative . | Reactive . | Total . |
| N (column %) . | N (column %) . | N (column %) . | |
| Age group, years | |||
| 18–24 | 2 (2.3) | 1 (9.1) | 3 (3.1) |
| 25–29 | 23 (26.4) | 2 (18.2) | 25 (25.5) |
| 30–34 | 25 (28.7) | 4 (36.4) | 29 (29.6) |
| 35–39 | 21 (24.1) | 2 (18.2) | 23 (23.5) |
| 40+ | 16 (18.4) | 2 (18.2) | 18 (18.4) |
| Race | |||
| Asian | 4 (4.6) | 0 (0.0) | 4 (4.1) |
| Black/African American | 18 (20.7) | 5 (45.5) | 23 (23.5) |
| Native Hawaiian/Pacific Islander | 2 (2.3) | 0 (0.0) | 2 (2.0) |
| White | 28 (32.2) | 4 (36.4) | 32 (32.7) |
| Other/refused | 35 (40.2) | 2 (18.2) | 37 (37.8) |
| Ethnicity | |||
| Hispanic/Latino | 37 (42.5) | 3 (27.3) | 40 (40.8) |
| Not Hispanic/Latino | 43 (49.4) | 6 (54.5) | 49 (50.0) |
| Other/refused | 7 (8.0) | 2 (18.2) | 9 (9.2) |
| Sexual orientation | |||
| Gay | 44 (50.6) | 7 (63.6) | 51 (52.0) |
| Bisexual | 16 (18.4) | 1 (9.1) | 17 (17.3) |
| Heterosexual | 19 (21.8) | 2 (18.2) | 21 (21.4) |
| Other/refused | 8 (9.2) | 1 (9.1) | 9 (9.2) |
| HIV status | |||
| Living with HIV | - | 3 (27.3) | - |
| Not living with HIV | - | 8 (72.7) | - |
| Condomless sex in the past 12 months | |||
| Condomless sex | - | 5 (45.5) | - |
| No condomless sex | - | 0 (0.0) | - |
| Unknown/refused | - | 6 (54.5) | - |
| Number of sexual partners | |||
| 0–1 | - | 0 (0.0) | - |
| 2–9 | - | 3 (27.3) | - |
| 10–19 | - | 3 (27.3) | - |
| 20–29 | - | 0 (0.0) | - |
| 30–39 | - | 0 (0.0) | - |
| 40+ | - | 2 (18.2) | - |
| Unknown/refused | - | 3 (27.3) | - |
| STI coinfection | |||
| No coinfection | - | 6 (54.5) | - |
| Gonorrhea only | - | 4 (36.4) | - |
| Chlamydia and syphilis | - | 1 (9.1) | - |
| Antibiotic resistance | - | ||
| No resistance | - | 1 (9.1) | - |
| Macrolide -23S rRNA | - | 9 (81.8) | - |
| Fluoroquinolone-parC | - | 0 (0.0) | - |
| Fluoroquinolone-gyrA | - | 0 (0.0) | - |
| Macrolide -23S rRNA and fluoroquinolone-parC | - | 1 (9.1) | - |
| Total (row %) | 87 (88.8) | 11 (11.2) | 98 (100.0) |
| . | Mycoplasma genitalium test results . | . | |
|---|---|---|---|
| . | Negative . | Reactive . | Total . |
| N (column %) . | N (column %) . | N (column %) . | |
| Age group, years | |||
| 18–24 | 2 (2.3) | 1 (9.1) | 3 (3.1) |
| 25–29 | 23 (26.4) | 2 (18.2) | 25 (25.5) |
| 30–34 | 25 (28.7) | 4 (36.4) | 29 (29.6) |
| 35–39 | 21 (24.1) | 2 (18.2) | 23 (23.5) |
| 40+ | 16 (18.4) | 2 (18.2) | 18 (18.4) |
| Race | |||
| Asian | 4 (4.6) | 0 (0.0) | 4 (4.1) |
| Black/African American | 18 (20.7) | 5 (45.5) | 23 (23.5) |
| Native Hawaiian/Pacific Islander | 2 (2.3) | 0 (0.0) | 2 (2.0) |
| White | 28 (32.2) | 4 (36.4) | 32 (32.7) |
| Other/refused | 35 (40.2) | 2 (18.2) | 37 (37.8) |
| Ethnicity | |||
| Hispanic/Latino | 37 (42.5) | 3 (27.3) | 40 (40.8) |
| Not Hispanic/Latino | 43 (49.4) | 6 (54.5) | 49 (50.0) |
| Other/refused | 7 (8.0) | 2 (18.2) | 9 (9.2) |
| Sexual orientation | |||
| Gay | 44 (50.6) | 7 (63.6) | 51 (52.0) |
| Bisexual | 16 (18.4) | 1 (9.1) | 17 (17.3) |
| Heterosexual | 19 (21.8) | 2 (18.2) | 21 (21.4) |
| Other/refused | 8 (9.2) | 1 (9.1) | 9 (9.2) |
| HIV status | |||
| Living with HIV | - | 3 (27.3) | - |
| Not living with HIV | - | 8 (72.7) | - |
| Condomless sex in the past 12 months | |||
| Condomless sex | - | 5 (45.5) | - |
| No condomless sex | - | 0 (0.0) | - |
| Unknown/refused | - | 6 (54.5) | - |
| Number of sexual partners | |||
| 0–1 | - | 0 (0.0) | - |
| 2–9 | - | 3 (27.3) | - |
| 10–19 | - | 3 (27.3) | - |
| 20–29 | - | 0 (0.0) | - |
| 30–39 | - | 0 (0.0) | - |
| 40+ | - | 2 (18.2) | - |
| Unknown/refused | - | 3 (27.3) | - |
| STI coinfection | |||
| No coinfection | - | 6 (54.5) | - |
| Gonorrhea only | - | 4 (36.4) | - |
| Chlamydia and syphilis | - | 1 (9.1) | - |
| Antibiotic resistance | - | ||
| No resistance | - | 1 (9.1) | - |
| Macrolide -23S rRNA | - | 9 (81.8) | - |
| Fluoroquinolone-parC | - | 0 (0.0) | - |
| Fluoroquinolone-gyrA | - | 0 (0.0) | - |
| Macrolide -23S rRNA and fluoroquinolone-parC | - | 1 (9.1) | - |
| Total (row %) | 87 (88.8) | 11 (11.2) | 98 (100.0) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
